Holder evidence
50
SEC ownership of Oric Pharmaceuticals, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001796280.
Lead holder
Nextech Crossover I GP S.a r.l.
13D/G signal
Nextech Crossover I GP S.a r.l.
Latest evidence
31 Mar 2026
- CIK
- 0001796280
- Symbol
- ORIC on Nasdaq
- Location
- South San Francisco, CA
- SEC evidence mix
- 13D/G, 13F, and 3/4/5
- Lead holder
- Nextech Crossover I GP S.a r.l.
- Latest large-stake holder
- Nextech Crossover I GP S.a r.l.
- Latest evidence date
- 31 Mar 2026
Issuer identity
Ownership snapshot
Ownership snapshot
Top shareholders of Oric Pharmaceuticals, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Nextech Crossover I GP S....
13D/G signal
Nextech Crossover I GP S....
Evidence rows
50
Latest as of
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 8.4%
13D/G row: Nextech Crossover I GP S.a r.l.
Showing 1-8 of 50 holder rows.
Rank 1 holder
Nextech Crossover I GP S.a r.l.
13D/G
- Ownership
- 8.4%
- Position
- $78.07M
Rank 2 holder
VIKING GLOBAL INVESTORS LP
13D/G
13F
- Ownership
- 7.8%
- Position
- $85.95M
Rank 3 holder
EcoR1 Capital, LLC
13F
13D/G
- Ownership
- 6.9%
- Position
- $85.25M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Nextech Crossover I GP S.a r.l. |
13D/G
|
8.4%
|
$78,072,743
7,162,637 shares
|
$0 | 30 Jun 2025 |
| VIKING GLOBAL INVESTORS LP |
13D/G
13F
Company
|
7.8%
|
$85,951,913
8,264,607 shares
|
-$4,833,275 | 31 Mar 2026 |
| EcoR1 Capital, LLC |
13F
13D/G
Company
|
6.9%
from 13D/G
|
$85,245,230
6,728,116 shares
|
— | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.6%
from 13D/G
|
$75,824,274
5,984,552 shares
|
— | 31 Mar 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
13D/G
Company · T. Rowe Price Associates, Inc.
|
5.4%
from 13D/G
|
$68,264,000
5,387,783 shares
|
— | 31 Mar 2026 |
| SR ONE CAPITAL MANAGEMENT, LLC |
13D/G
|
4.8%
|
$50,307,686
4,615,384 shares
|
$0 | 12 Aug 2025 |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
13D/G
Company
|
4.6%
from 13D/G
|
$57,066,896
4,504,096 shares
|
— | 31 Mar 2026 |
| Venrock Healthcare Capital Partners III, L.P. |
13D/G
|
4.2%
|
$44,925,556
4,319,765 shares
|
-$14,107,236 | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$4,658,967.
Buys
$262,899
Insiders: 1
Sells
$4,921,866
Insiders: 4
Net
-$4,658,967
Shares: -406,514
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 28,000
Shares: 434,514
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 113,514 | $0 | $1,279,742 | -$1,279,742 |
| 6-9 | 0 | 261,000 | $0 | $3,024,731 | -$3,024,731 |
| 9-12 | 28,000 | 60,000 | $262,899 | $617,394 | -$354,495 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-13 of 13 reporting-owner rows connected to Oric Pharmaceuticals, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
13
Lead holder
PFIZER INC
Net 12M change
-$4,658,968
Latest report
24 Feb 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| PFIZER INC | 10%+ Owner | $46,160,752 | Mixed | 23 Dec 2022 | ||
| COLUMN GROUP II, LP | 10%+ Owner | $30,636,680 | Mixed | 12 Nov 2021 | ||
| Jacob Chacko | PRESIDENT AND CEO, Director | $6,098,431 | -$3,167,380 | -34% | Mixed | 02 Jan 2026 |
| Richard A. Heyman | Director | $3,059,636 | -$80,431 | -2.6% | Filing P/S | 16 Jan 2026 |
| Dominic Piscitelli | Chief Financial Officer | $1,202,461 | -$1,576,927 | -57% | Mixed | 24 Feb 2026 |
| Pratik S. Multani | Chief Medical Officer | $899,028 | -$97,129 | -9.8% | Mixed | 02 Jan 2026 |
| Lori Anne Kunkel | Director | $665,180 | Mixed | 02 Jan 2026 | ||
| Richard H. Scheller | Director | $335,640 | Mixed | 20 May 2021 | ||
| Angie You | Director | $264,040 | +$262,899 | +23041% | Filing P/S | 02 Jan 2026 |
| Peter Svennilson | Director, 10%+ Owner | Mixed | 16 Jun 2021 | |||
| Steven L. Hoerter | Director | Mixed | 02 Jan 2026 | |||
| Mardi Dier | Director | Mixed | 02 Jan 2026 | |||
| Carl L. Gordon | Director, 10%+ Owner | Mixed | 16 Jun 2021 |
Recent insider transactions for Oric Pharmaceuticals, Inc.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Reported value | Reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Dominic Piscitelli | ORIC | Common Stock | Sale | -43.3% | $702,686 | $13.51 | -52,000 | 68,148 | 24 Feb 2026 | Direct |
| Dominic Piscitelli | ORIC | Common Stock | Options Exercise | 76.3% | 52,000 | 120,148 | 24 Feb 2026 | Direct | ||
| Dominic Piscitelli | ORIC | Stock Option (right to buy) | Options Exercise | -26.5% | -52,000 | 144,500 | 24 Feb 2026 | Direct | ||
| Richard A. Heyman | ORIC | Common Stock | Sale | -1.48% | $38,415 | $12.00 | -3,200 | 213,072 | 16 Jan 2026 | See footnote |
| Richard A. Heyman | ORIC | Common Stock | Sale | -7.73% | $42,016 | $12.00 | -3,500 | 41,800 | 16 Jan 2026 | Direct |
| Angie You | ORIC | Stock Option (right to buy) | Award | 40,000 | 40,000 | 02 Jan 2026 | Direct | |||
| Lori Anne Kunkel | ORIC | Stock Option (right to buy) | Award | 40,000 | 40,000 | 02 Jan 2026 | Direct | |||
| Steven L. Hoerter | ORIC | Stock Option (right to buy) | Award | 40,000 | 40,000 | 02 Jan 2026 | Direct | |||
| Richard A. Heyman | ORIC | Stock Option (right to buy) | Award | 40,000 | 40,000 | 02 Jan 2026 | Direct | |||
| Mardi Dier | ORIC | Stock Option (right to buy) | Award | 40,000 | 40,000 | 02 Jan 2026 | Direct | |||
| Dominic Piscitelli | ORIC | Restricted Stock Unit | Award | 34,500 | 34,500 | 02 Jan 2026 | Direct | |||
| Dominic Piscitelli | ORIC | Stock Option (right to buy) | Award | 206,500 | 206,500 | 02 Jan 2026 | Direct | |||
| Pratik S. Multani | ORIC | Restricted Stock Unit | Award | 35,500 | 35,500 | 02 Jan 2026 | Direct | |||
| Pratik S. Multani | ORIC | Stock Option (right to buy) | Award | 214,000 | 214,000 | 02 Jan 2026 | Direct | |||
| Jacob Chacko | ORIC | Restricted Stock Unit | Award | 112,500 | 112,500 | 02 Jan 2026 | Direct | |||
| Jacob Chacko | ORIC | Stock Option (right to buy) | Award | 675,000 | 675,000 | 02 Jan 2026 | Direct | |||
| Pratik S. Multani | ORIC | Common Stock | Sale | -13.6% | $97,129 | $9.06 | -10,720 | 68,149 | 16 Dec 2025 | Direct |
| Dominic Piscitelli | ORIC | Common Stock | Sale | -13.6% | $97,127 | $9.06 | -10,720 | 68,148 | 16 Dec 2025 | Direct |
| Jacob Chacko | ORIC | Common Stock | Sale | -5.43% | $302,368 | $9.06 | -33,374 | 581,711 | 16 Dec 2025 | Direct |
| Pratik S. Multani | ORIC | Common Stock | Options Exercise | 59.2% | 29,333 | 78,869 | 15 Dec 2025 | Direct | ||
| Pratik S. Multani | ORIC | Restricted Stock Unit | Options Exercise | -100% | -29,333 | 0 | 15 Dec 2025 | Direct | ||
| Dominic Piscitelli | ORIC | Common Stock | Options Exercise | 59.2% | 29,333 | 78,868 | 15 Dec 2025 | Direct | ||
| Dominic Piscitelli | ORIC | Restricted Stock Unit | Options Exercise | -100% | -29,333 | 0 | 15 Dec 2025 | Direct | ||
| Jacob Chacko | ORIC | Common Stock | Options Exercise | 15.7% | 83,666 | 615,085 | 15 Dec 2025 | Direct | ||
| Jacob Chacko | ORIC | Restricted Stock Unit | Options Exercise | -100% | -83,666 | 0 | 15 Dec 2025 | Direct | ||
| Lori Anne Kunkel | ORIC | Common Stock | Options Exercise | 13.5% | 10,000 | 84,200 | 08 Dec 2025 | Direct | ||
| Lori Anne Kunkel | ORIC | Stock Option (right to buy) | Options Exercise | -39.1% | -10,000 | 15,600 | 08 Dec 2025 | Direct | ||
| Lori Anne Kunkel | ORIC | Common Stock | Options Exercise | 8.06% | 5,534 | 74,200 | 04 Dec 2025 | Direct | ||
| Lori Anne Kunkel | ORIC | Stock Option (right to buy) | Options Exercise | -100% | -5,534 | 0 | 04 Dec 2025 | Direct | ||
| Dominic Piscitelli | ORIC | Common Stock | Sale | -18.5% | $159,719 | $14.52 | -11,000 | 48,317 | 06 Oct 2025 | Direct |
| Dominic Piscitelli | ORIC | Common Stock | Options Exercise | 22.8% | 11,000 | 59,317 | 06 Oct 2025 | Direct | ||
| Dominic Piscitelli | ORIC | Stock Option (right to buy) | Options Exercise | -5.3% | -11,000 | 196,500 | 06 Oct 2025 | Direct | ||
| Jacob Chacko | ORIC | Common Stock | Sale | -6.59% | $461,520 | $12.32 | -37,461 | 531,419 | 06 Oct 2025 | Direct |
| Richard A. Heyman | ORIC | Common Stock | Options Exercise | 262.4% | 32,800 | 45,300 | 03 Oct 2025 | Direct | ||
| Richard A. Heyman | ORIC | Stock Option (right to buy) | Options Exercise | -100% | -32,800 | 0 | 03 Oct 2025 | Direct | ||
| Jacob Chacko | ORIC | Common Stock | Sale | -8.52% | $638,805 | $12.05 | -53,001 | 568,880 | 01 Oct 2025 | Direct |
| Jacob Chacko | ORIC | Common Stock | Sale | -5.26% | $414,750 | $12.01 | -34,538 | 621,881 | 30 Sep 2025 | Direct |
| Jacob Chacko | ORIC | Common Stock | Sale | -16% | $1,349,938 | $10.80 | -125,000 | 656,419 | 22 Sep 2025 | Direct |
| Dominic Piscitelli | ORIC | Common Stock | Sale | -29.3% | $200,972 | $10.05 | -20,000 | 48,317 | 01 Jul 2025 | Direct |
| Dominic Piscitelli | ORIC | Common Stock | Sale | -32.2% | $341,039 | $10.50 | -32,466 | 68,317 | 24 Jun 2025 | Direct |
| Dominic Piscitelli | ORIC | Common Stock | Sale | -1.02% | $10,344 | $10.00 | -1,034 | 100,783 | 23 Jun 2025 | Direct |
| Angie You | ORIC | Common Stock | Purchase | 5.28% | $13,230 | $9.43 | 1,403 | 28,000 | 23 Jun 2025 | Direct |
| Angie You | ORIC | Common Stock | Purchase | $249,669 | $9.39 | 26,597 | 26,597 | 20 Jun 2025 | Direct | |
| Dominic Piscitelli | ORIC | Common Stock | Sale | -0.29% | $3,000 | $10.00 | -300 | 101,817 | 12 Jun 2025 | Direct |
| Dominic Piscitelli | ORIC | Common Stock | Sale | -2.83% | $29,777 | $10.01 | -2,976 | 102,117 | 11 Jun 2025 | Direct |
| Dominic Piscitelli | ORIC | Common Stock | Sale | -0.31% | $3,240 | $10.00 | -324 | 105,093 | 10 Jun 2025 | Direct |
| Dominic Piscitelli | ORIC | Common Stock | Sale | -0.29% | $3,000 | $10.00 | -300 | 103,864 | 09 Jun 2025 | Direct |
| Dominic Piscitelli | ORIC | Common Stock | Sale | -2.44% | $26,021 | $10.01 | -2,600 | 104,164 | 06 Jun 2025 | Direct |
* indicates a reported price that failed the local validity check.